Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-10

Clinical Trial Update: Lower Lugol's Solution Concentration on Reducing the Adverse Symptoms of Chromoendoscopy With Iodine Staining [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing lower concentrations of Lugol's solution to reduce mucosal irritation and improve image quality during chromoendoscopy with iod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lugol's solution (potassium iodide solution)

Snippet

Sponsor: Shandong University | Conditions: Mucosal Irritation, Image Quality | Phase 2 | Status: COMPLETED